Intelgenx Technologs Stock Analysis
| IGXT Stock | USD 0.17 0.00 0.00% |
Intelgenx Technologs is overvalued with Real Value of 0.14 and Hype Value of 0.17. The main objective of Intelgenx Technologs pink sheet analysis is to determine its intrinsic value, which is an estimate of what Intelgenx Technologs is worth, separate from its market price. There are two main types of Intelgenx Technologs' stock analysis: fundamental analysis and technical analysis.
The Intelgenx Technologs pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Intelgenx |
Intelgenx Pink Sheet Analysis Notes
About 23.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.07. Intelgenx Technologs had not issued any dividends in recent years. IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada. Intelgenx Technologs operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Intelgenx Technologs is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Intelgenx Technologs call Horst Zerbe at 514 331 7440 or check out https://www.intelgenx.com.Intelgenx Technologs Investment Alerts
| Intelgenx Technologs generated a negative expected return over the last 90 days | |
| Intelgenx Technologs has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 1.53 M. Net Loss for the year was (9.31 M) with loss before overhead, payroll, taxes, and interest of (721 K). | |
| Intelgenx Technologs currently holds about 6.98 M in cash with (7.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Roughly 23.0% of the company shares are held by company insiders |
Intelgenx Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 37.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Intelgenx Technologs's market, we take the total number of its shares issued and multiply it by Intelgenx Technologs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Intelgenx Technologs technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Intelgenx Technologs Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Intelgenx Technologs middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Intelgenx Technologs. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Intelgenx Technologs Outstanding Bonds
Intelgenx Technologs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Intelgenx Technologs uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Intelgenx bonds can be classified according to their maturity, which is the date when Intelgenx Technologs has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US45824TBC80 Corp BondUS45824TBC80 | View | |
| IFCCN 5459 22 SEP 32 Corp BondUS45823TAL08 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| INTELLIGENT PACKAGING LTD Corp BondUS45827MAA53 | View |
About Intelgenx Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Intelgenx Technologs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Intelgenx shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Intelgenx Technologs. By using and applying Intelgenx Pink Sheet analysis, traders can create a robust methodology for identifying Intelgenx entry and exit points for their positions.
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada. Intelgenx Technologs operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Intelgenx Technologs to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Additional Tools for Intelgenx Pink Sheet Analysis
When running Intelgenx Technologs' price analysis, check to measure Intelgenx Technologs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelgenx Technologs is operating at the current time. Most of Intelgenx Technologs' value examination focuses on studying past and present price action to predict the probability of Intelgenx Technologs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelgenx Technologs' price. Additionally, you may evaluate how the addition of Intelgenx Technologs to your portfolios can decrease your overall portfolio volatility.